Correlates of Age at Attainment of Developmental Milestones in HIV-infected Infants Receiving Early Antiretroviral Therapy: ERRATUMThe Pediatric Infectious Disease Journal: August 2015 - Volume 34 - Issue 8 - p 892 doi: 10.1097/INF.0000000000000835 Errata Free Article OutlineOutline Article MetricsMetrics REFERENCE In the article on page 55, volume 34, issue 1, there are editorial errors in the abstract. It is important to note that lopinavir/ritonavir was associated with a better outcome. The third sentence in the Results section of the abstract should appear as “Infants receiving nevirapinevs lopinavir/ritonavir-based ART attained later speech (18.1 vs. 15.5 months, P = 0.003).” The first sentence in the Conclusion section of the abstract should appear as “In HIV-infected infants, compromised pre-ART immune and growth status, poor post-ART immune and growth responses, and use of nevirapine- vs. lopinavir/ritonavir-based ART were each associated with later milestone attainment.”Back to Top | Article Outline REFERENCE 1. Benki-Nugent S, Eshelman C, Wamalwa D, et al. Correlates of Age at Attainment of Developmental Milestones in HIV-infected Infants Receiving Early Antiretroviral Therapy. Pediatr Infect Dis J. 2015;34:55–61 View Full Text | PubMed | CrossRef Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.